Recherche - Archive ouverte HAL

69 résultats

	Pour les 69 documents Envoyer sur ORCID RSS ATOM Exporter BibTeX XML-TEI CSV RTF EndNote PDF HTML Export avancé	Page : Page précédente 1 2 3 Page suivante	triés par Pertinence Auteur A→Z Auteur Z→A Titre A→Z Titre Z→A Date de publication croissante Date de publication décroissante Date de dépôt croissante Date de dépôt décroissante

		Towards novel treatment options in von Willebrand disease Peter J. Lenting , Claire Kizlik-Manson , Caterina Casari Haemophilia, 2022, 28 (S4), pp.5-10. ⟨10.1111/hae.14518⟩ Article dans une revue hal-04456557v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		The VWF/LRP4/aVb3-axis represents a novel pathway regulating proliferation of human vascular smooth muscle cells Jérémy Lagrange , Morel Worou , Jean-Baptiste Michel , Alexandre Raoul , Mélusine Didelot , et al. Cardiovascular Research, 2022, 118 (2), pp.622-637. ⟨10.1093/cvr/cvab042⟩ Article dans une revue hal-03267669v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		A inducible mouse model of Factor X deficiency to test novel FX therapeutics Sebastien Verhenne , Loubiere C , Cécile Denis , Peter J. Lenting , Olivier Christophe XXVIIth Congress of the International Society on Thrombosis and Haemostasis, International Society on Thrombosis and Haemostasis, Jul 2019, Melbourne (AUS), Australia. pp.Abstract OC 28.4 Communication dans un congrès hal-04499851v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		L'angiopoïétine-2 se lie à de multiples sites interactifs au sein du facteur von Willebrand Alexis Texier , Peter J. Lenting , Cécile Denis , Stéphanie Roullet , Olivier Christophe 44ème congrès de la Société Française d'Hématologie, Société Française d'Hématologie, Mar 2024, Paris, France. pp.P327, Abstract 18-03 Communication dans un congrès inserm-04541054v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Hemophilia A treatment innovation: factor VIII mimetic bispecific antibodies—generational enhancement David Lillicrap , Peter J. Lenting Journal of Thrombosis and Haemostasis, 2024, 22 (2), pp.352-355. ⟨10.1016/j.jtha.2023.10.026⟩ Article dans une revue hal-04465554v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Camelid‐derived single‐chain antibodies in hemostasis: Mechanistic, diagnostic, and therapeutic applications Ivan Peyron , Claire Kizlik‐masson , Marie‐daniéla Dubois , Sénadé Atsou , Stephen Ferrière , et al. Research and Practice in Thrombosis and Haemostasis, 2020, 4 (7), pp.1087-1110. ⟨10.1002/rth2.12420⟩ Article dans une revue hal-03116405v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		von Willebrand Factor Is a Critical Mediator of Deep Vein Thrombosis in a Mouse Model of Diet-Induced Obesity Alison Michels , Courtney Dwyer , Jeffrey Mewburn , Kate Nesbitt , Charlotte Kawecki , et al. Arteriosclerosis, Thrombosis, and Vascular Biology, 2020, 40 (12), pp.2860-2874. ⟨10.1161/ATVBAHA.120.314690⟩ Article dans une revue hal-04455764v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Coagulation biomarkers are independent predictors of increased oxygen requirements in COVID‐19 Antoine Rauch , Julien Labreuche , Fanny Lassalle , Julien Goutay , Morgan Caplan , et al. Journal of Thrombosis and Haemostasis, 2020, Journal of Thrombosis and Haemostasis, 18 (11), pp.2942-2953. ⟨10.1111/jth.15067⟩ Article dans une revue hal-04357399v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		VWF clearance: it’s glycomplicated Cécile Denis , Peter J. Lenting Blood, 2018, HITH, 131 (8), pp.842-843. ⟨10.1182/blood-2018-01-824904⟩ Article dans une revue hal-04449623v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Targeting protease nexin-1, a natural anticoagulant serpin, to control bleeding and improve hemostasis in hemophilia Karen Aymonnier , Charlotte Kawecki , Laurence Venisse , Yacine Boulaftali , Olivier D Christophe , et al. Blood, 2019, 134 (19), pp.1632-1644. ⟨10.1182/blood.2019000281⟩ Article dans une revue inserm-03116956v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Antithrombin-lowering in hemophilia: a closer look at fitusiran Guy Young , Peter J. Lenting , Stacy Croteau , Beatrice Nolan , Alok Srivastava Research and Practice in Thrombosis and Haemostasis, 2023, 7 (4), pp.100179. ⟨10.1016/j.rpth.2023.100179⟩ Article dans une revue hal-04454466v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Maladie de Willebrande type 2B et thrombopénies : Impact de la désialylation des plaquettes. Annabelle Dupont , Christelle Soukaseum , Frédéric Adam , Paulette Legendre , Valérie Proulle , et al. 38th Congress of the Société Française d’Hématologie, Société Française d’Hématologie, Mar 2018, Paris, France. pp.Page 143, Abstract 12-88 Communication dans un congrès hal-04457466v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		von Willebrand Factor for Aortic Valve Intervention Flavien Vincent , Antoine Rauch , Valentin Loobuyck , Mouhamed Moussa , Francis Juthier , et al. Circulation Research, 2018, 122 (11), pp.1499-1500. ⟨10.1161/CIRCRESAHA.118.312859⟩ Article dans une revue hal-04455821v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Targeting Protease Nexin-1, a natural anticoagulant to control bleeding in hemophilia A Karen Aymonnier , Charlotte Kawecki , Laurence Venisse , Emmanuelle de Raucourt , Olivier Christophe , et al. 2nd European Congress on Thrombosis and Haemostasis, Oct 2018, Marseille, France Communication dans un congrès hal-04457505v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		The von Willebrand Factor A1 domain mediates thromboinflammation, aggravating ischemic stroke outcome in mice Frederik Denorme , Kimberly Martinod , Aline Vandenbulcke , Cecile Denis , Peter J. Lenting , et al. Haematologica, 2020, pp.haematol.2019.241042. ⟨10.3324/haematol.2019.241042⟩ Article dans une revue inserm-02552320v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		A FVIII-Mimetic Bispecific Antibody with an Embedded Self-Regulation Mechanism Reduces the Risk of Prothrombotic Events for the Treatment of Haemophilia a Vincent Muczynski , Angel Smith , Thibaud Sefiane , Olivier Christophe , Peter J. Lenting , et al. ASH abstracts, Nov 2022, San Diego (CA), United States. pp.677-678, ⟨10.1182/blood-2022-169482⟩ Communication dans un congrès hal-04501469v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Transplacental Delivery of Maternal FVIII for Induction of FVIII-specific Immune Tolerance Angelina Mimoun , Melissa Bou Jaoudeh , Ivan Peyron , Victoria Daventure , Sandrine Delignat , et al. Hybrid Congress of the International Society on Thrombosis and Haemostasis, International Society on Thrombosis and Haemostasis, Jul 2021, Philadelphia (Pennsylvania), United States. pp.Abstract OC 14.1 Communication dans un congrès hal-04501088v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Coagulation markers are independent predictors of increased oxygen requirements and thrombosis in COVID‐19: Response from Original Authors Susen, et al. Sophie Susen , Antoine Rauch , Peter J Lenting Journal of Thrombosis and Haemostasis, 2020, 18 (12), pp.3385-3386. ⟨10.1111/jth.15101⟩ Article dans une revue hal-04357393v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Thrombin-mediated activation of factor VIII is insufficient to produce all necessary cofactor activity in vivo Charlotte Kawecki , Ivan Peyron , Amine Bazaa , Vincent Muczynski , Stephen Ferrière , et al. Congress of the International Society of Thrombosis and Haemostasis, Research and Practice in Thrombosis and Haemostasis, 3, pp.1-891, 2019, ⟨10.1002/rth2.12229⟩ Proceedings/Recueil des communications hal-04461945v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Targeting Protease Nexin-1, a natural anticoagulant to control bleeding in hemophilia A Karen Aymonnier , Charlotte Kawecki , Laurence Venisse , Emmanuelle de Raucourt , Olivier Christophe , et al. XXVIIth Congress of the International Society on Thrombosis and Haemostasis, International Society on Thrombosis and Haemostasis, Jul 2019, Melbourne (AUS), Australia. pp.Abstract OC 75.3 Communication dans un congrès hal-04498448v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Développement d’un modèle de souris avec un déficit inductible en facteur X Sebastien Verhenne , Loubière Cécile , Elena Barbon , F Mingozzi , Cécile Denis , et al. 39th Congress of the Société Française d’Hématologie, Société Française d’Hématologie, Mar 2019, Paris, France. pp.Abstract 12-29 Communication dans un congrès hal-04498403v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Shear Force-Induced Platelet Clearance Is a New Mechanism of Thrombocytopenia Antoine Rauch , Annabelle Dupont , Mickael Rosa , Maximilien Desvages , Christina Le Tanno , et al. Circulation Research, 2023, 133 (10), pp.826-841. ⟨10.1161/CIRCRESAHA.123.322752⟩ Article dans une revue hal-04455871v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		von Willebrand factor: from figurant to main character in the scene of inflammation Peter J. Lenting , Alexis Texier , Caterina Casari Journal of Thrombosis and Haemostasis, 2023, 21 (4), pp.710-713. ⟨10.1016/j.jtha.2023.01.014⟩ Article dans une revue hal-04456671v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		In vivo modulation of a dominant‐negative variant in mouse models of von Willebrand disease type 2A Matteo Campioni , Paulette Legendre , Cécile Loubiere , Barbara Lunghi , Mirko Pinotti , et al. Journal of Thrombosis and Haemostasis, 2020, Online ahead of print. ⟨10.1111/jth.15131⟩ Article dans une revue inserm-02983110v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Development and characterization of single‐domain antibodies neutralizing protease nexin‐1 as tools to increase thrombin generation Charlotte Kawecki , Karen Aymonnier , Stephen Ferrière , Laurence Venisse , Véronique Arocas , et al. Journal of Thrombosis and Haemostasis, 2020, 18, pp.2155-2168. ⟨10.1111/jth.14940⟩ Article dans une revue inserm-02934843v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins Giulia Pavani , Marine Laurent , Anna Fabiano , Erika Cantelli , Aboud Sakkal , et al. Nature Communications, 2020, 11 (1), pp.3778. ⟨10.1038/s41467-020-17552-3⟩ Article dans une revue inserm-02946890v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		A hemophilia A mouse model for the in vivo assessment of emicizumab function Stephen Ferrière , Ivan Peyron , Olivier D. Christophe , Charlotte Kawecki , Caterina Casari , et al. Blood, 2020, 136 (6), pp.740-748. ⟨10.1182/blood.2019004334⟩ Article dans une revue inserm-02916896v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Antithrombotic Potential of a Single-domain Antibody Enhancing the Anticoagulant Activity of Protein S Josepha Sedzro , Frédéric Adam , Allan De Carvalho , Elsa P Bianchini , Ivan Peyron , et al. Hybrid Congress of the International Society on Thrombosis and Haemostasis, International Society on Thrombosis and Haemostasis, Jul 2021, Philadelphia (Pennsylvania), United States. pp.Abstract OC 60.2 Communication dans un congrès hal-04501112v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		A reactive center loop–based prediction platform to enhance the design of therapeutic SERPINs Wariya Sanrattana , Thibaud Sefiane , Simone Smits , Nadine van Kleef , Marcel Fens , et al. Proceedings of the National Academy of Sciences of the United States of America, 2021, 118 (45), ⟨10.1073/pnas.2108458118⟩ Article dans une revue hal-04455790v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Antibodies in the Treatment of Haemophilia A—A Biochemical Perspective Stephen Ferrière , Peter J. Lenting Hämostaseologie, 2019, 39 (01), pp.036-041. ⟨10.1055/s-0038-1677521⟩ Article dans une revue hal-04456615v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More

Filtrer vos résultats

Towards novel treatment options in von Willebrand disease

The VWF/LRP4/aVb3-axis represents a novel pathway regulating proliferation of human vascular smooth muscle cells

A inducible mouse model of Factor X deficiency to test novel FX therapeutics

L'angiopoïétine-2 se lie à de multiples sites interactifs au sein du facteur von Willebrand

Hemophilia A treatment innovation: factor VIII mimetic bispecific antibodies—generational enhancement

Camelid‐derived single‐chain antibodies in hemostasis: Mechanistic, diagnostic, and therapeutic applications

von Willebrand Factor Is a Critical Mediator of Deep Vein Thrombosis in a Mouse Model of Diet-Induced Obesity

Coagulation biomarkers are independent predictors of increased oxygen requirements in COVID‐19

VWF clearance: it’s glycomplicated

Targeting protease nexin-1, a natural anticoagulant serpin, to control bleeding and improve hemostasis in hemophilia

Antithrombin-lowering in hemophilia: a closer look at fitusiran

Maladie de Willebrande type 2B et thrombopénies : Impact de la désialylation des plaquettes.

von Willebrand Factor for Aortic Valve Intervention

Targeting Protease Nexin-1, a natural anticoagulant to control bleeding in hemophilia A

The von Willebrand Factor A1 domain mediates thromboinflammation, aggravating ischemic stroke outcome in mice

A FVIII-Mimetic Bispecific Antibody with an Embedded Self-Regulation Mechanism Reduces the Risk of Prothrombotic Events for the Treatment of Haemophilia a

Transplacental Delivery of Maternal FVIII for Induction of FVIII-specific Immune Tolerance

Coagulation markers are independent predictors of increased oxygen requirements and thrombosis in COVID‐19: Response from Original Authors Susen, et al.

Thrombin-mediated activation of factor VIII is insufficient to produce all necessary cofactor activity in vivo

Targeting Protease Nexin-1, a natural anticoagulant to control bleeding in hemophilia A

Développement d’un modèle de souris avec un déficit inductible en facteur X

Shear Force-Induced Platelet Clearance Is a New Mechanism of Thrombocytopenia

von Willebrand factor: from figurant to main character in the scene of inflammation

In vivo modulation of a dominant‐negative variant in mouse models of von Willebrand disease type 2A

Development and characterization of single‐domain antibodies neutralizing protease nexin‐1 as tools to increase thrombin generation

Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins

A hemophilia A mouse model for the in vivo assessment of emicizumab function

Antithrombotic Potential of a Single-domain Antibody Enhancing the Anticoagulant Activity of Protein S

A reactive center loop–based prediction platform to enhance the design of therapeutic SERPINs

Antibodies in the Treatment of Haemophilia A—A Biochemical Perspective